Ultraviolet A1 Radiation Induces Nitric Oxide Synthase-2 Expression in Human Skin Endothelial Cells in the Absence of Proinflammatory Cytokines  by Suschek, C.V. et al.
Ultraviolet A1 Radiation Induces Nitric Oxide Synthase-2
Expression in Human Skin Endothelial Cells in the Absence of
Proin¯ammatory Cytokines
C. V. Suschek, D. Bruch-Gerharz,* H. Kleinert,² U. FoÈrstermann,² and V. Kolb-Bachofen
Research Group Immunobiology, *Department of Dermatology, MED-Heinrich-Heine-University of DuÈsseldorf, DuÈsseldorf, Germany; ²Department
of Pharmacology, Johannes Gutenberg University, Mainz, Germany
Skin exposure to ultraviolet radiation from sunlight
causes erythema and edema formation as well as
in¯ammatory responses. As some of these ultravio-
let-induced effects are potentially mediated by nitric
oxide synthases, we examined the role of cytokines
and ultraviolet A1 radiation (340±400 nm) on the
expression of the nitric oxide synthase-2 in endothe-
lia of normal human skin biopsies during short-term
organ culture as well as expression and activity of
the nitric oxide synthase-2 in in vitro cell cultures of
human dermal endothelial cells. Both, cytokine chal-
lenge (interleukin-1b + tumor necrosis factor-
a + interferon-g) but also ultraviolet A1 exposure
(50 J per cm2) in the absence of cytokines led to the
expression of nitric oxide synthase-2 in human skin
organ cultures as shown by immunohistochemistry.
Moreover, exposing human dermal endothelial cell
cultures to proin¯ammatory cytokines but also to
ultraviolet A1 radiation (6±24 J per cm
2) in the
absence of cytokines resulted in signi®cant nitric
oxide synthase-2 mRNA and protein expression as
well as enzyme activity. Ultraviolet A1 irradiation of
cytokine activated cells led to further increases in
nitric oxide synthase-2 mRNA, protein expression,
and enzyme activity. Moreover, a reporter gene
assay using a human nitric oxide synthase-2 pro-
moter construct provide evidence that ultraviolet A1,
in the absence of cytokines, induces nitric oxide
synthase-2 expression and activity, as previously
shown for cytokines. Thus, the results presented here
demonstrate for the ®rst time that in dermal
endothelia of human skin ultraviolet A1 radiation
alone represents a proin¯ammatory stimulus suf®-
cient to initiate nitric oxide synthase-2 expression as
well as activity comparable with the respective
response seen in the presence of proin¯ammatory
cytokines. Key words: healing cytokines/endothelial cells/
human skin/nitric oxide/nitric oxide synthase-2/ultraviolet
A1. J Invest Dermatol 117:1200±1205, 2001
N
itric oxide (NO) and equal amounts of citrulline are
synthesized from the guanidino nitrogen of L-
arginine by nitric oxide synthases (NOS). This
enzyme family comprises of two different subfami-
lies: two constitutively expressed and calcium/
calmodulin-dependent isoenzymes, the endothelial NOS-3 and
the neuronal NOS-1 and an inducible and calcium-independent
isoenzyme (NOS-2). Upon agonist stimulation, the constitutive,
calcium-dependent enzymes generally produce short-lasting pulses
(seconds to minutes) of NO. In contrast, NOS-2 once expressed
following inducing challenges, synthesizes NO for comparatively
long periods (days) of time (FoÈrstermann et al, 1994).
During in¯ammatory processes cytokines are known modulators
of endothelial cell functions (Prober and Cotran, 1990). One of the
prominent effects that cytokines can exert on endothelial cells is the
induction of the NOS-2 expression and ensuing high-output NO
synthesis (Suschek et al, 1993, 1994), serving local protection from
infectious agents (Liew and Cox, 1991), but also shown to be
involved in immune-mediated local tissue destruction, e.g, as in
autoimmune diabetes or in septic shock (KroÈncke et al, 1998).
NOS-2-generated NO has been thought of as a toxic effector
molecule usually, but more recently it was shown to act in
immunoregulation (Kolb and Kolb-Bachofen, 1998) and as a
protective agent, e.g, against ultraviolet (UV) A1-induced apoptosis
(Suschek et al, 1999).
Prolonged exposure of the human skin to UV radiation can
result in adverse effects, including erythema and edema formation,
in¯ammation, premature aging, immune suppression, and skin
cancer (Jagger, 1985; Grange, 1987). Erythema formation is the
result of local increases in blood ¯ow in both the super®cial and
deep vascular plexus of the dermis (Greaves, 1986). UV radiation-
induced erythema were shown to be signi®cantly reduced by
inhibitors of NOS (Goldsmith et al, 1996) demonstrating a direct or
indirect involvement of NO in the regulation of the local UV-
induced response of normal human skin (Bruch-Gerharz et al,
1998a,b).
This study examined the effects of UVA1 radiation (340±
400 nm) and cytokines on the expression of the NOS-2 in
specimens of normal human skin maintained in organ culture as
well as expression and activity of the NOS-2 in human dermal
endothelial cells (HUDEC). Data presented show that UVA1
radiation can initiate endothelial NOS-2 promoter activity and
Manuscript received July 18, 2000; revised March 2, 2001; accepted for
publication June 28, 2001.
Reprint requests to: Prof. Dr. Victoria Kolb-Bachofen, Institute of
Immunobiology Geb. 14.80, MED-Heinrich-Heine-University, PO Box
10 10 07. Email: bachofen@uni-duesseldorf.de
Abbreviation: UVA1, ultraviolet radiation A1.
0022-202X/01/$15.00 ´ Copyright # 2001 by The Society for Investigative Dermatology, Inc.
1200
NOS-2 expression to a degree comparable with proin¯ammatory
cytokine challenge.
MATERIALS AND METHODS
Cells HUDEC (two separate batches) were purchased from PromoCell
(Heidelberg, Germany) and were maintained for up to six passages in
endothelial cell basal medium supplemented with 15% fetal bovine serum
(FBS) 2 mM L-glutamine, 2 mM L-arginine, 100 mg streptomycin per
ml, 100 U penicillin per ml, 250 ng amphotericin B per ml, but without
hydrocortisone, epidermal growth factor, and endothelial cell growth
supplement. The human cell line A549/8 was from ATCC (American
Type Culture Collection, Rockville, MD) and was grown in Dulbecco's
modi®ed Eagle's medium/10% FBS.
UVA1 challenge and cytokine activation Examining the effects of
UVA1 on NOS-2 induction, HUDEC or A549/8 cells were irradiated
with nontoxic doses of 3, 6, 12, 18, and 24 J per cm2 UVA1. The
appearance of apoptotic cell death could be observed after irradiation
with UVA1 at intensities > 28 J per cm
2. It is known that during UVA1
irradiation of human skin, only 20±50% of the light penetrate the
epidermis and reach the dermal vasculature (Bruls et al, 1984a,b;
Meunier, 1999). Thus, we calculated that 50 J per cm2 represent a
nontoxic dose of UVA1 radiation suf®cient for NOS-2 induction in
vessel endothelia in human skin specimens.
Examining the effects of cytokines, with skin organ cultures we used a
combination of interleukin (IL)-1b, tumor necrosis factor (TNF)-a
(1000 U per ml each), and 200 U per ml interferon (IFN)-g that was
found to be effective in NOS-2 induction in primary human keratino-
cytes (Bruch-Gerharz et al, 1996). With HUDEC, we used a combin-
ation of IL-1b, TNF-a, and/or IFN-g (500 U per ml each) that was
previously shown to be effective in rat endothelial cells as well as
HUDEC (Suschek et al, 1993; Hoffmann et al, 1999). For the sake of
comparability, exactly the same cytokines were used with the NOS-2-
promoter transfected A549/8 cells.
Experimental design Human skin specimens were derived from
mammoplastic surgery (Department of Plastic Surgery, Florence
Nightingale Hospital, DuÈsseldorf, Germany), cut into 4 mm squares and
placed in 24-well culture plates with RPMI/20% FBS supplemented
with 0.1 mg penicillin per ml, 0.1 mg streptomycin per ml, and 0.25 mg
amphotericin B per ml. Skin specimens were incubated for 24 h with
cytokines or irradiated with UVA1 (50 J per cm
2) and cultured for 24 h.
Specimens were then embedded in Tissue-Tek (Reichert-Jung, Vienna,
Austria) and snap frozen in liquid nitrogen for immunohistochemical
characterization.
Experiments with HUDEC, were performed with cells from passages
2 to 6. Endothelial cells (1 3 105) were cultured in 24-well tissue
culture plates. Resident or cytokine activated HUDEC were then
irradiated with UVA1 at doses indicated. Viability of endothelial cells was
routinely controlled at the beginning and end of each experiment by
neutral red staining (Finter, 1969) and trypan blue exclusion.
Stable transfection of A549/8 cells; analysis of the human NOS-2
promoter activity To generate A549/8 cells stably transfected with a
construct containing a 16 kb fragment of the human NOS-2 promoter
cloned in front of a luciferase reporter gene cells were transfected by
lipofection with DOTAP according to the manufacturer's
recommendations using 4.5 mg of pNOS2(16)Luc (de Vera et al, 1996)
and 0.5 mg of pRc-CMV (Invitrogen (Karlsruhe, Germany); containing
a neomycin resistance gene). The transfected cells were selected by G
418 treatment (1 mg per ml). Different cell clones were analyzed for
luciferase activity and checked for integration of the transfected DNA by
polymerase chain reaction (PCR).
Resident or cytokine activated (IL-1b, TNF-a, IFN-g, IL-
1b + TNF-a, IL-1b + IFN-g, TNF-a + IFN-g or cytokine mix con-
sisting of all three cytokines) A549/8 cells were irradiated with 18 J per
cm2 UVA1. Extracts (200 ml) were prepared 12 h later using the
luciferase assay lysis buffer. The luciferase activities of the extracts (diluted
1 : 50 in lysis buffer) were determined using the Luciferase Assay System
and normalized to the number of cells in the respective probes
determined immediately prior to lysis by measuring neutral red uptake.
Relative NOS-2-promoter activity is given in percent of controls
(resident stable transfected A549/8 cells = 100%).
Immunohistochemistry of skin cryostat sections Cryostat sections
from skin specimens (7 mm) were ®xed with 0.2% glutaraldehyde.
Blocking of unspeci®c binding was performed with 0.5% bovine serum
albumin in Tris-buffered saline for 30 min. Endothelium was
characterized using the anti-von Willebrand factor anti-serum or
monoclonal antibodies anti-CD31, anti-CD34, or anti-ecNOS.
Additionally, sections from cytokine-activated skin specimens as well as
skin specimens irradiated with UVA1 (50 J per cm
2) were incubated with
a monoclonal antibody anti-NOS-2. As secondary antibodies peroxidase-
conjugated goat anti-rabbit or goat anti-mouse IgG were used and
visualized after reaction with diaminobenzidine and hydrogen peroxide
Immunocytochemistry For immunocytochemistry of HUDEC, these
were grown to subcon¯uency on sterile glass coverslips. Cells were
washed with phosphate-buffered saline and ®xed with acetone at ±20°C
for 10 min. Blocking of unspeci®c binding, endothelial cell
characterization, and NOS-2-speci®c staining was performed as described
above.
HUDEC con®rmed the expected positive phenotype for von
Willebrand factor, CD31, CD34, and ecNOS (data not shown). Labeling
experiments also showed that the cell cultures consisted of pure
endothelial cells, as the respective staining patterns with the endothelial
speci®c markers were found in all cells (data not shown).
Nitrite determination After 24 h of incubation, nitrite concentrations
in culture supernatants was determined using the Griess reaction as
modi®ed by Wood et al (1990) and NaNO2 as standard.
PCR Total cellular RNA was prepared from cytokine-stimulated or
resident endothelial cells or from UVA1 irradiated resident or cytokine-
activated cells and was used for cDNA synthesis with dT16
oligonucleotides as primer. Reverse transcription was carried out at 42°C
for 60 min. The cDNA was then used as a template for PCR using
oligonucleotides and cycle pro®les shown in Table I. Using the NOS-2
primer oligonucleotides, we obtained a 393 bases long NOS-2-speci®c
ampli®cation product. It exhibits a 100% homology to the human
cDNA sequence of exons 8±11 as revealed by sequence analysis (data not
shown). An aliquot of each reaction was subjected to electrophoresis on
1.8% agarose gels. Bands were visualized by ethidium bromide staining.
Densitometric analysis of the ampli®cation products was performed on
digital images using the KODAK 1D software (KODAK, Stuttgart,
Germany).
Western blot analysis of the NOS-2 protein Endothelial cells
(7 3 106 each), treated as indicated were then washed, lyzed (Novex,
San Diego, CA), scraped from the dishes, transferred to a
microcentrifuge tube, boiled for 5 min, subjected to gel electrophoresis
(50 mg protein per well) in 10% sodium dodecyl sulfate±polyacrylamide
gels, and transferred to nitrocellulose membranes. Incubations of the
blots were: 1 h with blocking buffer (2% bovine serum albumin, 5%
nonfat milk powder, 0.1% Tween 20 in phosphate-buffered saline
buffer), 1 h with a 1 : 1000 dilution of the anti-NOS-2 antibody,
washed, 1 h with a 1 : 2000 dilution of the secondary horseradish
peroxidase conjugated rabbit anti-mouse IgG antibody, incubated for
5 min in ECL reagent (Pierce, Rockford, IL), placed into a plastic bag
and exposed to an enhanced autoradiographic ®lm. To control for equal
loading of total protein in all lanes, blots were also stained with a 1:2000
solution of the mouse anti-a-tubulin antibody and a secondary
horseradish peroxidase conjugated goat anti-mouse IgG antibody (diluted
1:2000 prior to use).
Reagents Recombinant human IL-1b, IFN-g, and TNF-a were
obtained from HBT (Leiden, the Netherlands) and Genzyme
(Cambridge, MA), L-glutamine, L-arginine, streptomycin, penicillin,
amphotericin B, Neutral Red (3% solution), type I collagen, collagenase
(from Clostridium histolyticum), and rabbit anti-human von Willebrand
factor anti-serum, and monoclonal antibody anti-a-tubulin from Sigma
(Deisenhofen, Germany), the monoclonal antibodies anti-CD31 and
anti-CD34 from Dako (Glostrup, Denmark), the monoclonal antibodies
anti-NOS-2 and anti-ecNOS from Transduction Laboratories
(Lexington, KT), peroxidase-conjugated porcine anti-rabbit IgG from
DAKO (Hamburg, Germany), and peroxidase-conjugated goat anti-
mouse IgG from Zymed Laboratories (San Francisco, CA), trypsin,
ethylenediamine tetraacetic acid, FBS (endotoxin free), RPMI-1640
(endotoxin free), Dulbecco's modi®ed Eagle's medium, the oligo dT16
primer, Geneticin G 418, DOTAP, Luciferase Assay System, and Taq-
polymerase from Boehringer Mannheim (Mannheim, Germany) or
Gibco Laboratories (Eggenstein, Germany), 3,3¢-diaminobenzidine from
Serva GmbH (Heidelberg, Germany), medium and supplements for
HUDEC cultures from Promo Cell GmbH. The UVA1 source (4000 W
lamp emitting the UVA1 spectrum from 340 to 400 nm) as well as the
dosimeter was purchased from Sellas Medizinische GeraÈte (Gevelsberg,
Germany). The NOS-2 inhibitor L-N5-(1-Iminoethyl)-ornithin was a
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kind gift from Boehringer Mannheim. LPS concentrations of RPMI
1640/FBS plus cytokines were below 0.1 ng per ml.
Statistical analysis Data are given as the arithmetical mean 6 SD.
Signi®cances were calculated using Student's t test (two-tailed for
independent samples).
RESULTS
Cytokines or UVA1 initiates induction of NOS-2 in
endothelia of human skin In organ cultures of normal
human skin specimens aliquots were either incubated with
proin¯ammatory cytokines as indicated for 24 h or exposed to
UVA1 radiation (50 J per cm
2) and then cultured for 24 h without
any additions. Samples were snap frozen and cryostat sections were
stained for NOS-2 protein expression. As shown in Fig 1, cytokine
challenge rendered the vessel-lining dermal endothelia strongly
positive for NOS-2 protein. Vessel endothelia of UVA1-irradiated
skin specimens also exhibited the same positive signals, whereas
sham-treated resident and nonirradiated controls were essentially
negative.
Induction of NOS-2 in dermal endothelial cells after
cytokine challenge or UVA1 irradiation Next, we
examined whether UVA1 irradiation in vitro would lead to NOS-
2 expression in HUDEC cultures. Resident cells were irradiated
with UVA1 at intensities indicated and after an additional culture
period of 24 h NOS-2 mRNA and protein expression was
determined by reverse transcription±PCR, immunocyto-
chemistry, or western blot technique, respectively. As shown in
Fig 2, UVA1 irradiation (3±24 J per cm
2) at and above 6 J per cm2
led to the induction of NOS-2 mRNA and NOS-2 protein
expression. As a positive control, cytokine incubation of HUDEC
(IL-1b + TNF-a + IFN-g, 500 U per ml each) led to NOS-2
mRNA and NOS-2 protein expression as reported previously
(Hoffmann et al, 1999).
UVA1 augments expression and activity of cytokine-
induced NOS-2 in dermal endothelial cells Combination
of UVA1 irradiation with subsequent cytokine challenge (Fig 3 and
Table II) resulted in strongly augmented increases of NOS-2
mRNA (2-fold), protein (2.5-fold), and nitrite levels in culture
Table I. Oligonucleotide sequences and cycle pro®les used in reverse transcription±PCR
Product
Sequence
(5¢®3¢) Bases
GenBank
accession no.
Product
size (bases)
Human NOS-2 sense TGCCAGATGGCAGCATCAGA 1021±1040 L09210 393
anti-sense TTTCCAGGCCCATTCTCCTGC 1394±1413
Human GAPDH sense CAACTACATGGTTTACATGTTCC 153±175 M17851 416
anti-sense GGACTGTGGTCATGAGTCCT 549±568
Product Cycle pro®les
Human NOS-2 40 3 (30¢¢ 90°C, 60¢¢ 58°C, 60¢¢ 72°C) + 5¢ 72°C
Human GAPDH 25 3 (30¢¢ 90°C, 30¢¢ 60°C, 30¢¢ 72°C) + 5¢ 72°C
Figure 1. Expression of NOS-2 protein in
endothelia of skin specimens after cytokine
challenge or UVA1 irradiation. To detect the
endothelial NOS-2 protein in cytokine-activated
(1000 U per ml IL-1b + 1000 U per ml TNF-
a + 200 U per ml IFN-g) endothelia of skin
biopsies immunohistochemistry was performed
using an NOS-2-speci®c monoclonal antibody.
Additionally, skin specimens were exposed to
UVA1 radiation (50 J per cm
2) and 24 h after
irradiation immunohistochemistry was performed
using the monoclonal antibody anti-NOS-2. With
cryostat sections of human skin biopsies vessel
endothelia of cytokine-activated skin stained
positively for NOS-2 (B). A positive signal for the
NOS-2 was also found in skin endothelia after
irradiation of skin specimens with UVA1 (C). No
signal was found in untreated skin (A). Scale bar:
100 mM.
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supernatants (1.9- or 1.5-fold) as compared with cultures that were
irradiated only or cytokine challenged only.
Effects of UVA1 radiation on NOS-2 promoter
activity The results described above may implicate a direct
NOS-2 induction by UVA1 radiation in the absence of cytokines.
We therefore tested the effects of UVA1 (18 J per cm
2) on the
NOS-2 promoter activity using the human A549/8 cell line stably
transfected with a human NOS-2 promoter luciferase reporter gene
construct (Fig 4). UVA1 irradiation of cells in the absence of
cytokines, increased NOS-2 promoter activity by a factor of 2.
Incubation with any combination of two cytokines (500 U per ml
each) led to identical increases in luciferase activity, whereas
incubation with single cytokines (500 U per ml each) had no
effects. A combination of UVA1 plus any of the single cytokines did
not increase the response seen with UVA1 alone. In contrast, UVA1
irradiation in combination with the presence of two cytokines
strongly augmented NOS-2 promoter activity by a factor of
approximately 5 when compared with sham treatment or by a
factor of 2.5 when compared with UVA1 alone, or two cytokines
alone. Maximal NOS-2 promoter activity was achieved after
incubation with three cytokines and here UVA1 irradiation did not
lead to further increases in luciferase activity. Thus, UVA1 radiation
will initiate NOS-2 promoter activity in the absence of exogenous
cytokines and may maximize cytokine-induced NOS-2 promoter
activity.
DISCUSSION
With the results in this study we show that the induction of NOS-2
expression represents a local response of dermal cells to UVA1
irradiation in the absence of any additional exogenous proin-
¯ammatory stimuli. It had been shown previously that UVA1 will
penetrate the epidermis reaching the dermal vasculature (Bruls et al,
1984b; Meunier, 1999). Thus, NOS-2 expression in skin
endothelia is likely to represent a relevant event contributing to
erythema formation after sunlight exposure or UVA1 irradiation
(Goldsmith et al, 1996). Additionally, we show that proin¯amma-
tory cytokines will induce dermal endothelial NOS-2 expression in
situ in human skin specimens.
The data presented here, especially those obtained with reporter
gene assays all prove a direct induction of NOS-2 gene expression
by UVA1 irradiation at levels comparable with a mixture of
proin¯ammatory cytokines. Previous studies on UVA1-induced
modulation of gene expression, performed with ®broblasts or
keratinocytes, had demonstrated a dominant involvement of the
transcription factors NF-kB (Vile et al, 1995), AP-1 (Soriani et al,
2000), and AP-2 (Grether-Beck et al, 1997). Unfortunately, to
date, nothing is known about the effects of UVA1 radiation on the
activation of NOS-2-relevant transcription factors.
Although AP-2 binding sites are present on the NOS-2
promoter, 5¢-deletion and mutation analysis gave no evidence for
a role in NOS-2-activity regulation. On the other hand, mutation
analysis of the NOS-2 promoter construct also used in this study,
clearly demonstrated several NF-kB binding sites far upstream and
con®rmed that inducibility requires NF-kB binding sites upstream
of ±4.7 kb (de Vera et al, 1996; Nunokawa et al, 1996; Taylor et al,
1998). Intracellular production of reactive oxygen intermediates as
a result of UVA1 exposure is a generally accepted pathway
(McCormick et al, 1976; Cunningham et al, 1985; Tyrrell and
Pidoux, 1989) and NOS-2 expression is sensitive to the cellular
redox state (Adcock et al, 1995). Thus, UVA1-induced oxidative
stress and subsequent activation of NF-kB (Forman and Cadenas,
1997), may represent the inducing event for NOS-2 expression
(Murphy, 1999); however, our ®ndings of UVA1-mediated
increases in cytokine-induced NOS-2 expression or activity are
not fully compatible with NF-kB activation as the sole UVA1-
induced events, because the cytokine mixture also uses NF-kB
activation among others.
Figure 2. UVA1 irradiation induces NOS-2
mRNA and protein expression in HUDEC.
HUDEC were exposed to UVA1 radiation (3±
24 J per cm2) and 24 h after irradiation NOS-2-
speci®c reverse transcription±PCR (A), western
blot analysis (B), or immunochemistry (C) was
performed, respectively. Irradiation of HUDEC
cultures with UVA1 leads to both, induction of
NOS-2 mRNA as well as protein expression. As
positive control, NOS-2 expression was also seen
after cytokine challenge (500 U per ml IL-
1b + 500 U per ml TNF-a + 500 U per ml
IFN-g). Scale bar: 100 mM.
Table II. Nitrite formation in culture supernatants of
HUDEC after UVA1 and/or cytokine challenge
HUDEC
nitrite (nM)
HUDEC + L-NIO
nitrite (nM)
Resident 370 6 100 180 6 130
UVA1 700 6 110
a 110 6 100c
IL-1b + TNF-a 880 6 140a 140 6 110c
IL-1b + TNF-a + UVA1 1300 6 210b 70 6 120c
Resident or cytokine-activated (500 U IL-1b per ml + 500 U TNF-a per ml)
HUDEC (1 3 105) cultured in 24-well tissue culture plates in the presence or
absence of the NOS-inhibitor N5-iminoethyl-L-ornithine (L-NIO, 0.25 mM)
were irradiated with UVA1 (18 J per cm
2).After 24 h of incubation nitrite a stable
reaction product of NO was measured in culture supernatants using the Griess
reaction. Values represent the mean 6 SEM of three to six individual experiment.
ap < 0.001 as compared with resident cells.
bp < 0.001 as compared with UVA1-irradiated or cytokine-activated cells.
cp < 0.001 as compared with the respective cultures in the absence of L-NIO.
VOL. 117, NO. 5 NOVEMBER 2001 UVA1 INDUCES NOS-2 EXPRESSION IN ENDOTHELIAL CELLS 1203
Reactive oxygen species-mediated c-Jun/c-Fos (AP-1) acti-
vation (Torres and Forman, 2000), was recently shown to enhance
NOS-2 expression and activity strongly (Marks-Konczalik et al,
1998), and thus AP-1 may represent a candidate of UVA1/reactive
oxygen species-sensitive transcription factors. The involvement of
AP-1 in NOS-2 induction, however, remains controversial and a
suppressive activity for the NOS-2 promoter has also been reported
(Kleinert et al, 1998).
In conclusion, the data in this study demonstrated that UVA1
radiation can initiate endothelial NOS-2 expression in the
endothelia of human skin or in cultures of microvascular
HUDEC, a response that is comparable with the expression
achieved by proin¯ammatory cytokines. NOS-2 expression occurs
in keratinocytes of psoriatic skin (Kolb-Bachofen et al, 1994;
Bruch-Gerharz et al, 1996) and in the skin vasculature of patients
with atopic dermatitis, and allergic contact dermatitis (Rowe et al,
1997). Thus, this response may represent a key signal in regulating
local dermal functions during in¯ammation after various environ-
mental challenges (Bruch-Gerharz et al, 1998a,b).
Figure 4. UVA1 radiation enhances NOS-2-promoter activity. To
analyze the effect of UVA1 on NOS-2 promoter activity, resident or
cytokine-activated human alveolar epithelium-like A549/8 cells stably
transfected with a 16 kb fragment of the 5¢-¯anking sequence of the
human NOS-2 gene cloned before a luciferase reporter gene (white bars)
were irradiated with 18 J per cm2 UVA1 (gray bars). UVA1 irradiation of
resident cells augments NOS-2 promoter activity by the factor of
approximately 2. Incubation with single cytokines (IL-1b, TNF-a, or
IFN-g, 500 U per ml each) had no effects. Incubation with any
combination of two cytokines led to a approximately 2-fold increase in
luciferase activity and additional irradiation strongly augmented NOS-2
promoter activity by a total factor of 5 or a factor of 2.5 when compared
with cells treated with UVA1 alone or two cytokines alone. Maximal
NOS-2-promoter activity was achieved after incubation with the
cytokine mix (all three cytokines) but could not be augmented by
additional UVA1 challenge. Bars represent mean 6 SEM of four
individual experiments. *p < 0.001 as compared with resident cells or
cells activated with single cytokines. #p < 0.001 as compared with
resident cells 6 UVA1 or cells activated with single cytokines 6 UVA1.
Figure 3. UVA1 irradiation of HUDEC augments cytokine-
induced endothelial NOS-2 mRNA and NOS-2 protein
expression. Resident or cytokine-activated (500 U per ml IL-
1b + 500 U per ml TNF-a) HUDEC were exposed to UVA1 radiation
(18 J per cm2). After 24 h of incubation NOS-2 mRNA (A) or NOS-2
protein (B) was examined using NOS-2-speci®c reverse transcription±
PCR or western blot analysis, respectively. Cytokine challenge of
HUDEC leads to the induction of NOS-2 mRNA and protein
expression. UVA1 irradiation combined with subsequent cytokine
challenge led to signi®cant increases in the amount of the NOS-2
mRNA ampli®cation product as well as an apparent increase in protein
expression as compared with nonirradiated cytokine-challenged cells. (C)
Endothelial NOS-2 activity after UVA1 exposure or cytokine challenge
was signi®cantly augmented as compared with resident cells. Both stimuli
together led to an additional increase in nitrite formation. Bars represent
mean 6 SEM of three to eight individual experiments. *p < 0.001.
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